نتائج البحث 481-490 من 15612 لعملية البحث عن macular degeneration
placebo in combination with ado-trastuzumab emtansine (TTT-DM1) in patients with stage II-III HER2+ breast cancer with residual disease post-neoadjuvant ...
... disease, Cystinuria and APRT deficiency. This information will create a registry that will help us to compare similarities and differences in patients and ...
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to ...
Certain conditions also are better seen without contrast. Some people have health conditions that might make using contrast risky, such as kidney disease. In ...
Evaluating Optic Nerve Disease with OCT Angiography. Rochester, Minn. The purpose of this study is to determine if optical coherence tomography (OCT) ...
... disease stage. Multiscale EEG Dynamics. Rochester, Minn., Scottsdale/Phoenix, Ariz. The purpose if this study to combine state of the art cerebral signal ...
The purpose of this study is to evaluate sporadic (s-) and familial (f-) frontotemporal lobar degeneration (FTLD) patients and asymptomatic family members of f- ...
Also, to improve disease control by decreasing the number of spinal ... disease, or symptomatic radiation brain necrosis in patients with brain ...
Optometrist. Phoenix, AZ. مناطق التركيز: Eye exam, Contact lens fitting, Diabetes, Dry eyes, Glaucoma, Macular degeneration. Gregory ...
مناطق التركيز: Adrenal cancer, Thyroid cancer, Benign adrenal tumor, Thyroid nodule, Goiter, Neuroendocrine tumor, Hyperparathyroidism..., Graves' disease ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.